Our subject matter experts provided key insights on how to develop a robust first-in-human (FIH) regulatory CMC package for recombinant biological molecules by integrating the following activities into your project plan.
How to develop a robust first-in-human (FIH) regulatory CMC package for recombinant biological molecules
Should we have missed out on connecting at European Biomanufacturing Summit 2022, reach out to us to find out more about how we help pharma and new and emerging biotech companies turn pharmaceutical possibilities into realities and get to market faster.
Location: Virtual
Topic:
Biomanufacturing